• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVA BIOMEDICAL CORP STATSTRIP GLUCOSE HOSPITAL METER SYSTEM; BLOOD GLUCOSE METER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVA BIOMEDICAL CORP STATSTRIP GLUCOSE HOSPITAL METER SYSTEM; BLOOD GLUCOSE METER Back to Search Results
Model Number 54790
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Hypoglycemia (1912)
Event Date 01/26/2021
Event Type  malfunction  
Manufacturer Narrative
There was no reported patient harm or intervention.There is currently a pending investigation.Additional information and further details will be provided in a supplemental report.
 
Event Description
The customer reported to the fda (uf/importer report #: (b)(4)) that on (b)(6) 2021 a patient had a bedside glucose test done.The blood was collected by the phlebotomist and ran on the units glucometer at the bedside.The results was 54.However, the blood was collected and tested in the lab was 68.The customer concern is that neonatal blood sugars that are different can require treatment based on the numbers.According to the customer, the patient was not adversely affected by the incident.
 
Manufacturer Narrative
Additional and corrected information: b4, g6, h1, h2, h10.An investigation has been initiated and is currently pending.Further details will be provided in an additional supplemental report when they become available.
 
Manufacturer Narrative
Udi- (b)(4).The customer reported to the fda (uf/importer report #: 1002600000-2021-8001) a neonatal patient glucose result discrepancy while using their statstrip meter 1.86, on (b)(6) 2021.The blood was collected by the phlebotomist and ran on the units glucometer at the bedside.The customer stated that the nova meter generated a patient result of 54 but the lab result was 68, no patient impact was reported.During follow-up the customer provided two serial number (sn) of statstrip meter 1.86, (b)(6), and (b)(6) that is used at the clinic.The exact sn of the meter used was unable to be identified because the clinic uses both of their meters interchangeably.The customer was also unable to provide and test strip lot information.No materials were retuned for investigation and the test strip lot information was not provided.No further investigation was possible and no root cause was able to be identified.Device history record (dhr) reviews for the statstrip meter 1.86, (b)(6) and (b)(6),were performed by a quality control engineer.The reviews included an assessment of the production, testing, and release of the meters.No abnormalities or concerns were observed; the dhrs indicated that the released product met all specifications.No further investigation was possible as the customer did not returned materials for evaluation and could not provide any test strip lot information.However, nova previously performed a comprehensive study on four (4) different lots of statstrip glucose test strips, ages 3, 6, 12, and 18 months.The study evaluated samples with low glucose concentrations and high hematocrit concentrations to simulate venous whole blood neonatal blood specimens.The data meets the fda's acceptance criteria with much of the comparative data within +/- 5 mg/dl of the reference method and most within +/-10 mg/dl.This type of variability is expected against central laboratory systems.This shows that with proper sample collection and handling the system reports accurate results.Based on the increased frequency of similar complaints, regarding neonatal results, nova also revised ifus (instructions for use) for the appropriate products to include additional guidance for site preparation and heel stick sample collection for neonates.This effort was completed via preventive action 5142.The conclusion of this investigation is that the reported issue of discrepant neonatal glucose results, reported and documented in complaint (b)(4), could not be confirmed and thus, no root cause was able to be identified.A capa(corrective and preventative action) is not required as a result of this investigation because the complaint was not able to be confirmed.Nova will continue to monitor for recurrence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STATSTRIP GLUCOSE HOSPITAL METER SYSTEM
Type of Device
BLOOD GLUCOSE METER
Manufacturer (Section D)
NOVA BIOMEDICAL CORP
200 prospect street
waltham MA 02454 9141
MDR Report Key11507891
MDR Text Key242404757
Report Number1219029-2021-00014
Device Sequence Number1
Product Code PZI
UDI-Device Identifier00385480547901
UDI-Public00385480547901
Combination Product (y/n)N
PMA/PMN Number
K181043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number54790
Device Catalogue Number54790
Was Device Available for Evaluation? No
Date Manufacturer Received04/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-